Home/Filings/4/0001171843-25-002086
4//SEC Filing

Anderman Jonathan 4

Accession 0001171843-25-002086

CIK 0001738021other

Filed

Apr 7, 8:00 PM ET

Accepted

Apr 8, 9:30 AM ET

Size

4.6 KB

Accession

0001171843-25-002086

Insider Transaction Report

Form 4
Period: 2025-04-07
Anderman Jonathan
General Counsel
Transactions
  • Purchase

    Common Stock

    2025-04-07$1.54/sh+20,000$30,80021,000 total

Documents

1 file

Issuer

Compass Therapeutics, Inc.

CIK 0001738021

Entity typeother

Related Parties

1
  • filerCIK 0002032625

Filing Metadata

Form type
4
Filed
Apr 7, 8:00 PM ET
Accepted
Apr 8, 9:30 AM ET
Size
4.6 KB